$VLRX UP 40% PREMARKET ON NEW DATA

****** HUGE MOVE ON THE WAY TODAY, THIS COULD REALLY ROCKET HIGHER******************

Thinly traded micro cap Valeritas Holdings (NASDAQ:VLRX) is up 38% premarket on increased volume in reaction to new data from the VERDICT study, a real-world retrospective analysis of electronic medical records from a large diabetes center.

Patients with HbA1c levels greater than 9% are considered to have poor diabetes control. After five months of V-Go use, reductions in HbA1c of 1.5% were observed.

V-Go is a disposable insulin delivery device (patch) that is placed on the skin where it delivers basal/bolus insulin over a 24-hour period.

VALERITAS HOLDINGS INC.
Valeritas Holdings, Inc. is a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with diabetes. It offers products under the V-Go brand. V-Go Disposable Insulin Delivery Device, is used by patients with type 2 diabetes to maintain target blood glucose goals. The firm's single-use disposable V-Go device includes V-Go PreFill and V-Go Link.